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Abstract
Background: Canine diabetes mellitus (DM) is a common endocrine disease in domestic dogs. A number of
pathological mechanisms are thought to contribute to the aetiopathogenesis of relative or absolute insulin
deficiency, including immune-mediated destruction of pancreatic beta cells. DM risk varies considerably between
different dog breeds, suggesting that genetic factors are involved and contribute susceptibility or protection.
Associations of particular dog leucocyte antigen (DLA) class II haplotypes with DM have been identified, but
investigations to date have only considered all breeds pooled together. The aim of this study was to analyse an
expanded data set so as to identify breed-specific diabetes-associated DLA haplotypes.
Methods: The 12 most highly represented breeds in the UK Canine Diabetes Register were selected for study. DLA-
typing data from 646 diabetic dogs and 912 breed-matched non-diabetic controls were analysed to enable breed-
specific analysis of the DLA. Dogs were genotyped for allelic variation at DLA-DRB1, -DQA1, -DQB1 loci using DNA
sequence-based typing. Genotypes from all three loci were combined to reveal three-locus DLA class II haplotypes,
which were evaluated for statistical associations with DM. This was performed for each breed individually and for all
breeds pooled together.
Results: Five dog breeds were identified as having one or more DLA haplotype associated with DM susceptibility
or protection. Four DM-associated haplotypes were identified in the Cocker Spaniel breed, of which one haplotype
was shared with Border Terriers. In the three breeds known to be at highest risk of DM included in the study
(Samoyed, Tibetan Terrier and Cairn Terrier), no DLA haplotypes were found to be associated with DM.
Conclusions: Novel DLA associations with DM in specific dog breeds provide further evidence that immune
response genes contribute susceptibility to this disease in some cases. It is also apparent that DLA may not be
contributing obvious or strong risk for DM in some breeds, including the seven breeds analysed for which no
associations were identified.
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Plain English summary
Diabetes mellitus (DM) affects approximately 1 in 300
dogs in the UK and is much more common in some
breeds than others. Multiple factors and biological pro-
cesses are involved in canine DM. There is preliminary
evidence that genetic factors may explain why some
breeds are predisposed to, or protected from, developing
this disease. Previous evidence has indicated that the im-
mune system may contribute to destruction of the pan-
creas in diabetic dogs, similar to that seen in human
type 1 DM. A collection of genes encoding the dog
leucocyte antigens (DLA) play a critical role in regulat-
ing immune responses and previous studies have impli-
cated a role for these genes in canine DM. However, no
investigations have yet been conducted in individual
pedigree dog breeds. This study compared variation
within the DLA genes of diabetic and non-diabetic dogs
for 12 different breeds. In 5 breeds, increased risk for or
protection from DM was associated with particular DLA
gene variations. However, no associations were identified
in the three breeds at highest risk of DM included in the
study (Samoyed, Tibetan Terrier and Cairn Terrier).
This study supports a role for DLA-encoded immune
regulation in the development of DM in certain dog
breeds. Future studies of gene function in single breeds
will help identify causal variants and mechanisms, which
may lead to improved diagnosis and management of
affected dogs.
Background
Canine DM is a relatively common endocrinopathy en-
countered in routine veterinary clinical practice, with a
UK prevalence of 0.32–0.34% [1, 2]. Cases are diagnosed
on the basis of persistent fasting hyperglycaemia, persist-
ent glycosuria and compatible clinical signs [3]. Virtually
all diabetic dogs require daily insulin injections [3],
although the precise cause of the pancreatic beta cell
dysfunction/destruction remains elusive.
Most cases of canine DM are diagnosed in dogs aged
between 5 and 12 years of age [1]. A classification system
has been proposed, based on the underlying pathogen-
esis of the hyperglycaemia, namely either insulin defi-
ciency diabetes (IDD) or insulin resistance diabetes
(IRD) [4]. Further classification nomenclature has re-
cently been proposed by the European Society for Veter-
inary Endocrinology (ESVE) project ALIVE (Agreeing
Language in Veterinary Endocrinology) [5]. Apart from
female entire dogs, which can develop a form of IRD
during dioestrus or pregnancy, most cases of canine DM
can be classified as IDD [4]. However, the underlying
pathogenesis of insulin deficiency is likely to be complex
and heterogeneous. DM is likely to be the consequence
of a decline in pancreatic beta cell mass, resulting from
increased beta cell destruction and/or impaired beta cell
regeneration. Histopathological studies have reported re-
duced populations of beta cells in the pancreatic tissue
of diabetic dogs [6, 7]. This has prompted research into
whether beta cell loss occurs due to immune-mediated
destruction, as is the case in human Type 1 DM (T1D)
[8]. The most common autoantibodies identified in hu-
man T1D (against insulin, GAD-65 and IA-2) have been
detected in a small proportion of diabetic dogs [9–12];
other studies have failed to detect autoantibodies [13].
Lymphocytic infiltration of pancreatic islets, as seen at
the onset of human T1D [14, 15], has rarely been re-
ported in dogs [7, 13]. Therefore, the role of the adaptive
immune system in canine DM remains uncertain. It has
also been proposed that canine DM might be more simi-
lar to human latent autoimmune diabetes of adults
(LADA) rather than T1D [16]. This is a more slowly
progressive immune-mediated destruction of pancreatic
beta cells occurring in combination with other non-
immunological risk factors, leading to reduced beta cell
mass and insulin deficiency later in life.
The striking pattern of breed predispositions for ca-
nine DM strongly suggests that genetic risk factors con-
tribute to disease susceptibility. Breeds such as the
Samoyed, Yorkshire Terrier, Australian Terrier and
Miniature Schnauzer have all been reported to be at
high risk in independent studies, whereas the Boxer,
Golden Retriever and German Shepherd Dog are consid-
ered to be at low risk of developing DM [1, 2, 17, 18]. A
large number of diabetes susceptibility genes, each con-
tributing relatively small effects, have been identified in
human T1D [19], Type 2 DM (T2D) [20] and mono-
genic DM [21]. This has prompted candidate gene stud-
ies in canine DM, which have largely focussed on T1D
genes involved with immune function [22–25] and hu-
man monogenic diabetes genes [26].
Genes encoded within the major histocompatibility
complex (MHC) play critical roles in the regulation of
the adaptive immune response in higher species. These
roles include their involvement in the setting of baseline
immune tolerance, allowing distinction of ‘self’ antigens
from ‘non-self’ antigens, and also influencing the degree
of immune response that develops to particular antigens.
A striking feature of many of MHC loci is their extreme
levels of gene polymorphism. Certain MHC class II gene
polymorphisms are highly associated with the develop-
ment of autoimmune conditions and other immune-
mediated diseases in humans [27, 28] and other mam-
mals including dogs [29, 30].
Canine MHC genes, known as the dog leucocyte anti-
gen (DLA) genes are found on chromosome 12. There
are four functional class II MHC genes in the dog: DLA-
DRA1, -DRB1, -DQA1 and -DQB1 [31]. These encode
cell-surface heterodimers which bind antigenic peptides
in a peptide binding groove and present these to T cell
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receptors for regulation of the adaptive immune response.
DLA-DRA1 appears to be monomorphic, while the other
three functional class II genes are highly polymorphic,
resulting in diversity in the antigen binding capabilities of
the class II molecules. The extensive linkage disequilib-
rium in this region results in particular combinations of
alleles being found together as preferential haplotype com-
binations. Therefore, three-locus DLA class II haplotypes
of DLA-DRB1, -DQA1 and -DQB1 are often used to study
the relationship of the DLA to disease.
Just as some human HLA gene polymorphisms and
haplotype combinations are present or absent in some
ethnic groups, or are seen at different gene frequencies
in different populations, the same is observed across dif-
ferent pedigree dog breeds, but to even more extreme
levels [32, 33]. Furthermore, specific HLA-types influen-
cing disease risk vary between different human ethnic
populations [34, 35]. A previous candidate gene study,
investigating the role of the MHC in canine DM, identi-
fied four DLA haplotypes that were associated with dis-
ease risk or protection [25]. That study compared DLA
class II alleles and haplotypes in pooled populations of
dogs with canine DM to unaffected dogs, but did not
have sufficient sample sizes to enable analysis by individ-
ual breed. However, pooling of data between breeds can
obscure differences in DM pathogenesis that may exist
among breeds. Therefore, studying the role of DLA hap-
lotypes within individual breeds can improve under-
standing of the role of DLA genes in particular breeds
and help to identify those cases where underlying path-
ology may be similar.
The aim of the current study was to determine
whether specific DLA haplotypes are associated with risk
or protection from DM in individual dog breeds and
whether combined analysis of all 12 breeds would sup-
port the findings of the previous study. Identifying
whether DLA genes influence the risk of canine DM will
improve understanding of whether this endocrinopathy




EDTA blood samples from UK diabetic dogs, submitted
by veterinary surgeons to the Royal Veterinary College
(RVC) Canine Diabetes Register with informed consent
(Ethics Review Board number: URN 2017 1685–3), were
used for this study. A diagnosis of DM was made on the
basis of persistent hyperglycaemia, glucosuria and con-
sistent clinical signs. Dogs were either newly diagnosed
or had been receiving insulin treatment for a variable
period of time. Following diagnostic testing, residual
blood samples were made available for research. Samples
from female entire diabetic dogs were excluded, as these
were potentially affected with dioestrus diabetes. Where
age data were available, diabetic dogs < 6 months old at
diagnosis were also excluded as these were potentially
affected with a form of juvenile DM. Blood samples from
non-diabetic dogs were obtained from the RVC DNA
Archive and the Companion Animal DNA Archive (Uni-
versity of Manchester). Control samples with a recorded
clinical history of autoimmune disease were also
excluded.
To facilitate breed-specific analysis, 12 different dog
breeds were selected in which there were samples from
at least 20 cases, and where the number of controls was
equal to or greater than the number of cases. The sam-
ple size for each breed included in the study, and the
published odds ratio for UK population-based breed-
associated risks for DM [36], are summarised in Table 1.
DLA class II typing
Dogs were genotyped for three DLA class II loci: DLA-
DRB1, DLA-DQA1 and DLA-DQB1. The DLA data used
in a previous study [25] was also included in the present
study. The DLA-typing methods and primers used for
these samples are described in detail elsewhere [25]. The
additional samples used in this study were similarly ana-
lysed by DNA sequence-based typing of exon 2 for each
DLA locus, performed using a touchdown PCR protocol.
Primers are listed in Supplementary Table 1 [37–39].
Purification of PCR products was performed (ExoSAP-
IT PCR Clean-up Reagent, Applied Biosystems or GenE-
lute PCR Clean-Up Kit, Sigma-Aldrich) prior to DNA
sequencing using a standard Sanger sequencing protocol.
Sequencing data were analysed by either SBTengine
(GenDx, Genome Diagnostics B.V.) or MatchTools/
MatchTools Navigator (Applied Biosystems). DNA se-
quences were aligned to a consensus sequence and each
polymorphic site analysed electronically or manually. Se-
quences were electronically aligned against a reference
sequence library to assign the correct allele for each
locus. DLA haplotypes were subsequently assigned,
based on established DLA-types for each breed [40].
Statistical analysis
Haplotype counts were performed in Microsoft Excel for
cases and controls of each breed. Statistical analysis was
carried out using R software (R Foundation for Statistical
Computing). Contingency Tables were used to calculate
odds ratios; confidence intervals were determined using
Fisher’s Exact Test. Odds ratios were considered to be
significant when the upper and lower confidence inter-
vals did not cross 1.
Results
DLA haplotype frequencies observed in each breed are
summarised in Table 2 (higher risk breeds) and Table 3
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(lower risk breeds). For ease of reference, haplotype IDs
were arbitrarily assigned to the 30 most common haplo-
types observed in the study (Supplementary Table 2).
The two most common DLA haplotypes observed in the
study population were haplotype 1 (DRB1*001:01--
DQA1*001:01--DQB1*002:01; 13.6% cases vs. 12.1% con-
trols) and haplotype 6 (006:01--005:01:1--007:01; 14.1%
cases vs. 10.9% controls). These were also two of the
three most commonly observed haplotypes in the previ-
ous study [25].
The frequency of DLA haplotypes in cases and con-
trols was analysed separately for individual breeds. Eight
DLA haplotypes were significantly different comparing
cases and controls, across five breeds (Table 4). Four
haplotypes (IDs: 6, 7, 14 & 19) in the Cocker Spaniel
breed were associated with DM susceptibility or protec-
tion. Haplotype 6 (DLA 006:01--005:01:1--007:01) was
associated with DM risk (OR = 6.3, 95% CI: 3.1–13.7). In
contrast, haplotype 7 (006:01--005:01:01--020:01), which
only differs from risk haplotype 6 at the DQB1 locus,
was associated with protection against DM (OR = 0.30,
95% CI = 0.1–0.7). Similarly, haplotype 1 (001:01--001:
01--002:01), which was associated with increased DM
risk in Labrador Retrievers, only differs at the DQB1
locus from haplotype 2 (001:01--001:01--036:01), which
was associated with lower DM risk in West Highland
White Terriers (WHWT).
Haplotype 19 (015:01--006:01--020:02) was found to
be a DM protective haplotype in both the Cocker Span-
iel and Border Terrier breeds. No other DLA haplotypes
were associated with risk or protection in more than one
breed. Furthermore, no risk or protective haplotypes
were identified for the three breeds at greatest risk of
DM included in the study: the Samoyed, Tibetan Terrier
and Cairn Terrier.
All of the haplotypes identified as having some associ-
ation with DM in an individual breed were also carried
by multiple other breeds included in this study (Table
4). The most common haplotype in the Cocker Spaniel
breed (haplotype 6; 006:01--005:01:1--007:01) was also
found in all other breeds, apart from the four breeds
with the highest risk of developing DM (Samoyed, Cairn
Terrier, Tibetan Terrier and Miniature Schnauzer) and
the Border Terrier. This haplotype is common among
the general dog population, being found in 70% of dog
breeds, albeit at a wide range of frequencies (L.J. Ken-
nedy; personal communication).
A combined analysis of all 12 breeds was performed,
in order to compare findings more directly with the ob-
servations made in Kennedy et al. (2006). This analysis
revealed four haplotypes associated with DM risk or pro-
tection (Table 5). Three of these haplotypes had been as-
sociated with DM risk/protection in the individual
analysis of the Cocker Spaniel breed (IDs 6, 7 and 14;
Table 4). The remaining haplotype from the combined
analysis was not associated with DM risk in any individ-
ual breeds. None of the haplotypes from the combined
analysis had been significantly associated with risk of
DM in the previous study [25], in which a smaller num-
ber of dogs, representing a wider range of breeds, had
been examined together.
Analysis of high-risk breeds
Given that no haplotypes were identified as significantly
different between diabetic cases and non-diabetic con-
trols for the breeds at highest risk of canine DM
Table 1 DM risk for the specific breeds analysed [36] and samples sizes
Breed Case (n) Control (n) Published breed risk
of DM (odds ratio)
95% Confidence
interval
Samoyed 43 70 35.84 25.58–50.22
Tibetan Terrier 20 40 10.39 7.28–14.83
Cairn Terrier 30 30 9.76 7.27–13.09
Miniature Schnauzer 28 38 3.62 2.57–5.09
WHWT 133 150 3.04 2.55–3.63
Border Collie 57 87 2.02 1.64–2.5
Border Terrier 27 27 1.8 1.26–2.58
Labrador Retriever 111 240 1.67 1.43–1.94
Yorkshire Terrier 45 45 1.55 1.25–1.93
CKCS 48 48 1.41 1.08–1.85
Cocker Spaniel 55 80 1.25 0.97–1.6
JRT 49 57 0.61 0.48–0.77
Total (n) 646 912
Breeds are sorted based on the reported risk of DM [36]. n = number of dogs, CKCS Cavalier King Charles Spaniel, JRT Jack Russell Terrier, WHWT West highland
White Terrier
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(Samoyed, Tibetan Terrier and Cairn Terrier), the DLA
profiles for these high-risk breeds were examined in order
to identify any breed-associated patterns that may relate
to their predisposition to DM. The DLA haplotypes ob-
served in each of these three breeds are shown in Table 6.
The Samoyed breed was found to have a relatively re-
stricted DLA profile, with only seven different haplotypes.
Haplotype 18 (015:01--006:01--019:01--054:02), which carries
two alleles at the DQB1 locus, was only found in the Sam-
oyed dogs in this study and accounted for more than half of
the haplotypes identified in both cases (63.25%) and controls
(65%) of this breed. A second haplotype, (040:01--010:01--
019:01, no haplotype ID) was also found only in Samoyeds,
although at a relatively low frequency (4.4% cases, 3.6% con-
trols). The second most common haplotype in Samoyeds,
haplotype 10 (009:01--001:01--008:02) differs by a single
non-synonymous base-pair change from haplotype 9 (009:
01--001:01--008:01:1), which was also observed in the two
other highest risk breeds.
The Tibetan and Cairn Terriers were found to have a
more diverse DLA profile than Samoyeds, with 13
different haplotypes being identified in each breed. Six
haplotypes were identified exclusively within the Tibetan
Terrier breed. All of these were found at low frequency
except haplotype 22 (015:01-- 006:01--026:01), which
represented 7.5% of diabetic and 18.8% of control haplo-
types, and haplotype 30 (079:01--001:01--002:01) which
represented 30% of diabetic and 26.3% of control haplo-
types. Haplotype 1 (001:01--001:01--002:01), which was
found to confer diabetes risk in Labrador Retrievers
(Table 4), was also identified in Tibetan and Cairn Ter-
riers. However, this was one of the most common haplo-
types observed in the study. No haplotypes were
identified exclusively within the Cairn Terrier breed.
Discussion
The primary aim of this study was to identify whether
DLA class II haplotypes are associated with risk or protec-
tion from DM in individual UK dog breeds. A secondary
aim was to determine whether a pooled analysis of all 12
breeds included in the current study would support the
findings of the previous study by Kennedy et al. (2006).

























19 015:01 006:01 020:02 7.4 27.8 0.211 0.05–0.73 Protective 6
CKCS
(48/48)
28 020:01 004:01 013:03 35.4 16.7 2.73 1.33–5.81 Risk 5
Cocker Spaniel
(55/80)
6 006:01 005:01:1 007:01 89.1 56.3 6.31 3.14–13.65 Risk 6
7 006:01 005:01:1 020:01 8.2 23.1 0.297 0.12–0.66 Protective 3
14 012:01 004:01 017:01
–013:03
0.0 5.0 N/A 0–0.83 Protective 4
19 015:01 006:01 020:02 0.0 6.9 N/A 0–0.56 Protective 6
Labrador Retriever
(111/240)
1 001:01 001:01 002:01 20.3 13.8 1.59 1.02–2.47 Risk 7
WHWT
(133/150)
2 001:01 001:01 036:01 0.0 2.0 N/A 0–0.95 Protective 7
DLA class II haplotypes significantly associated (upper and lower 95% confidence intervals did not cross 1) with diabetes mellitus in individual breeds, calculated
using Fisher’s exact test. n = number of dogs, CKCS Cavalier King Charles Spaniel, WHWT West highland White Terrier, N/A Not applicable
Table 5 Combined analysis of all 12 breeds (only significant haplotypes shown)











6 006:01 005:01:1 007:01 14.1 10.9 1.34 1.07–1.67 Risk
7 006:01 005:01:1 020:01 1.7 3.0 0.557 0.32–0.93 Protective
14 012:01 004:01 017:01
–013:03
4.5 9.3 0.469 0.34–0.64 Protective
16 015:01 006:01 003:01 0.3 1.2 0.267 0.07–0.79 Protective
DLA class II haplotypes significantly associated (upper and lower 95% confidence intervals did not cross 1) with diabetes mellitus in combined analysis with all
breeds pooled together, calculated using Fisher’s exact test
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Our study indicated that no DLA haplotypes were associ-
ated with risk of DM in the ‘highest DM risk’ breeds
(Samoyed, Cairn Terrier, Tibetan Terrier and Miniature
Schnauzer). Five ‘moderate DM risk’ breeds were found to
possess DLA haplotypes that were associated with risk or
protection from DM; all of these haplotypes were also
present in other breeds, although only one DLA haplotype
was associated with protection from DM in more than
one breed (haplotype 19; DLA-DRB1*015:01--DQA1*006:
01--DQB1*020:02, found to confer protection in Cocker
Spaniel and Border Terrier breeds). These findings pro-
vide further evidence for the role of MHC class II and the
adaptive immune system in the pathogenesis of canine
DM in some breeds and suggest that the disease is likely
to be heterogeneous among breeds.
As a result of its popularity, the Labrador Retriever
was the most highly represented breed in this study (111
cases / 240 controls). It is a breed at a moderate [36] to
neutral [2] risk of developing DM. In this breed, DLA
haplotype 1 (001:01--001:01--002:01) was found to be as-
sociated with increased risk of DM (OR = 1.59, 95% CI =
1.02–2.47), which suggests that this particular DLA-type
might play a role in the pathogenesis of beta cell loss/
dysfunction in this breed. This DLA haplotype has previ-
ously been associated with increased risk of hypothyroidism
in Gordon Setters [41] as well as primary hypoadrenocorti-
cism (Addison’s disease; AD) in WHWT and Leonberger
breeds [42]. Notably, both hypothyroidism associated with
lymphocytic thyroiditis and primary hypoadrenocorticism
are considered to have an autoimmune basis and
Table 6 DLA haplotypes identified in cases and controls for the three highest-risk breeds included in the study
Haplotype
ID
Haplotype Samoyed Tibetan Terrier Cairn Terrier Comment












1 001:01 001:01 002:01 2.5 5.0 5 10 Risk haplotype in
Labrador Retriever
2 001:01 001:01 036:01 17.5 11.3
4 002:01 009:01 001:01 0 3
9 009:01 001:01 008:01:1 2.5 5.0 10 13
10 009:01 001:01 008:02 23.5 17.1
12 011:01 002:01 013:03 0 2
14 012:01 004:01 017:01–013:03 0 2 Protective haplotype in
combined analysis and
in Cocker Spaniel
16 015:01 006:01 003:01 0 3.6 0 8 Protective haplotype in
combined analysis
17 015:01 006:01 011:01 1.5 0 3 0
18 015:01 006:01 019:01–054:02 63.2 65 Unique to Samoyed
19 015:01 006:01 020:02 0 3
21 015:01 006:01 023:01 15.0 11.3 43 35
22 015:01 006:01 026:01 7.5 18.8 Unique to Tibetan Terrier
24 015:02 006:01 003:01 0.0 1.3
25 015:02 006:01 023:01 0 0.7 17.5 15.0 35 22
26 018:01 001:01 002:01 2 0
27 018:01 001:01 008:02 0 2
28 020:01 004:01 013:03 7.4 10 Risk haplotype in CKCS
30 079:01 001:01 002:01 30.0 26.3 Unique to Tibetan Terrier
001:01 002:01 036:01 2.5 0
015:02 006:01 054:01 2.5 0 Unique to Tibetan Terrier cases
015:03 006:01 013:05 0 1.3 Unique to Tibetan Terrier controls
015:03 006:01 023:01 0 1.3 Unique to Tibetan Terrier controls
017:01 002:01 013:03 2 0
040:01 010:01 019:01 4.4 3.6 Unique to Samoyed
112:01 001:01 008:01:2 2.5 3.8 Unique to Tibetan Terrier
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demonstrate breed differences in susceptibility [43, 44].
Additionally, the DLA-DRB1*001:01 allele has been found
to confer risk of anal furunculosis in GSDs [45, 46], sug-
gesting that this particular DRB1 allele may be important in
dysregulated inflammatory disease processes.
In the second most highly represented breed, the
WHWT (133 cases/150 controls), which is also the
breed at fifth highest risk of DM in this study, DLA
haplotype 2 (001:01--001:01--036:01) was associated
with protection from DM (95% CI = 0–0.95). This
haplotype was identified in 6 controls (2% of controls)
and not in any diabetic dogs, which supports a role
for this haplotype in protecting against DM in this
breed. However, because it was only identified in only
2% of controls and the 95% CI is very wide (0–0.95),
this association should be interpreted with caution
and further investigated in a larger cohort of
WHWTs. A similar observation was made by a study
of DLA class II haplotypes in AD [42]: the same
haplotype (001:01--001:01--036:01) was identified
solely in the control population of WHWTs (0 cases;
6 controls). However, this may be due to the WHWT
control population being much larger than the case
population in that study (43 cases; 166 controls).
Haplotype 2, associated with protection from DM in
WHWTs, differs only at the DQB1 locus from haplotype
1, associated with increased risk of DM in Labrador Re-
trievers, suggesting that the DQB1 locus influences dis-
ease susceptibility, or that it is in linkage disequilibrium
with other susceptibility loci within the MHC region.
Non-synonymous variants in a single locus may influence
disease risk by modifying the antigen binding capabilities
of the MHC molecules [47], particularly if these variants
occur in the hypervariable regions. For example, in human
T1D, polymorphisms at positions 56 and 57 of the DQB
chain are associated with either disease susceptibility or
resistance, according to the amino acid changes in the
peptide binding groove [48]. It has been suggested that
many risk haplotypes associated with organ-specific auto-
immune disease in dogs carry either DQA1*001:01--
DQB1*002:01 or DQA1*001:01--DQB1*008:02 haplo-
types [42]. The first of these DQ haplotypes is
present in haplotype 1 in this study (001:01--001:01--
002:01), associated with DM in the Labrador Re-
triever, however, the second was not present in any
haplotypes associated with DM in any of the 12
breeds in the present study. Further examination of
the role of these DQ haplotypes in autoimmune dis-
ease is warranted, particularly in relation to the effect
of variants on the ability of MHC molecules to bind
autoantigens and the influence of this on generation
of immune tolerance or autoimmunity.
The Cocker Spaniel, a breed with moderate risk for DM
[2, 36], is predisposed to autoimmune disease [49–52].
The DLA population profile of Cocker Spaniels is rela-
tively restricted, with most dogs of this breed carrying
DRB1*006:01--DQA1*005:01:1 with either DQB1*007:01
or DQB1*020:01 [32]. This restricted DLA profile might
be related to a relative hypersensitivity or impaired toler-
ance towards self-antigen. In the current study, Cocker
Spaniels were found to carry one DLA haplotype associ-
ated with increased risk of DM and three haplotypes asso-
ciated with protection from disease (Table 4), suggesting
that the MHC plays an important role in determining an
individual’s susceptibility to DM in this breed. The DLA
haplotype conferring risk, haplotype 6 (006:01--005:01:1--
007:01), is the most common haplotype in the breed and
is also carried, to some extent, in other dog breeds. In
contrast, haplotype 7 (006:01--005:01:1--020:01) confers
protection, again implicating the DQB1 locus in disease
susceptibility. A previous study of chronic pancreatitis in
English Cocker Spaniels also found that the DLA haplo-
type containing DQB1*007:01 was present in a signifi-
cantly greater proportion of cases, whereas the haplotype
containing DQB1*020:01 was more prevalent in the con-
trol population without evidence of pancreatitis [54]. The
authors of that study proposed that this suggests a predis-
position of English Cocker Spaniels for immune-mediated
disease more generally, since DQB1*007:01 has also been
implicated in primary immune-mediated haemolytic an-
aemia [30, 53]. The present study supports this assertion.
The DQB1*007:01 allele differs from DQB1*020:01 by 5
amino acids in a hypervariable region of DQB1 exon 2,
which has been previously defined [55]. The effect of these
amino acid changes on autoantigen binding and presenta-
tion by MHC molecules deserves further investigation.
Interestingly, no DLA haplotype associations with DM
were identified in the three breeds at highest risk of
canine DM: the Samoyed, Tibetan Terrier and Cairn
Terrier. It is possible that DM in these breeds is more
commonly of a non-immune-mediated aetiology and the
MHC plays a less significant role. However, an alterna-
tive explanation is that MHC alleles and haplotypes pre-
disposing to DM are not significantly different between
cases and controls but are present at high frequency
among the breed and exert a ‘fixed breed risk’ rather
than individual risk. The possibility of genes, such as the
MHC, exerting a fixed risk of DM within certain breeds
could be investigated by comparing breeds at high and
low risk of DM rather than comparing cases and controls
within single breeds. The most common haplotype in the
Samoyed breed in this study, haplotype 18 (015:01--006:
01--019:01--054:02), was present at high frequency among
both cases and controls (63.25% case and 65% control
haplotypes) and is exclusively found in this breed. It is
possible that this haplotype contributes to the high risk of
DM in the Samoyed breed, with other genetic and envir-
onmental factors combining to determine whether an
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individual develops DM. Similarly, six haplotypes were
identified exclusively within the Tibetan Terrier breed.
Those present at higher frequency (haplotypes 25 and 30)
may contribute to the increased risk of DM in this breed.
The two most common haplotypes observed in the
study (haplotypes 1 and 6) were also two of the most
common identified in the study by Kennedy et al.
(2006). This may reflect the fact that Labrador Retrievers
and certain terrier breeds (WHWT and Yorkshire Ter-
rier) were highly represented in both studies and a high
proportion of dogs in these breeds carry one or both of
these haplotypes. Furthermore, these two haplotypes are
common in the general dog population (L.J. Kennedy,
personal communication).
In the combined analysis with all breeds pooled to-
gether, four haplotypes were associated with risk or pro-
tection from DM (Table 5). However, three of these
were associated with risk or protection in Cocker Span-
iels, therefore the combined associations may have been
strongly influenced by the haplotype frequencies in this
breed. None of the three-locus DLA haplotype associa-
tions with canine DM in Kennedy et al. (2006) were rep-
licated in the present study. However, the 2-locus
DRB1--DQA1 haplotype associated with risk of canine
DM in the previous analysis (015--006) is present in a
protective haplotype (haplotype 16; 015:01--006:01--003:
01) in this study. The difference between the two studies
is likely to be due to the different number and range of
breeds included. Previously, a more heterogeneous
population of 87 breeds had been included at lower sam-
ple numbers per breed, compared with the current study
with a more limited breed profile (n = 12 breeds), but
each with a minimum of 20 cases and an expanded
population of breed-matched controls. The DLA haplo-
type diversity is known to be restricted within certain
breeds but very diverse between breeds [32, 33], there-
fore altering the relative breed frequencies will impact
on the representation of DLA haplotypes in the study
population. However, the diverse observations of the
two studies highlights how pooling of haplotypes be-
tween different breeds can conceal differences among
breeds and further emphasizes the need for breed-
specific approaches to study the genetics of canine com-
plex disease, such as DM.
There are a number of limitations to the present study
which must be considered. The use of sequence-based
typing of the MHC has been questioned by a study sug-
gesting that associations found by this method cannot
be replicated by a SNP genotyping method [56]. How-
ever, SBT allows DNA to be sequenced directly from
PCR and the use of specialist software (SBT-Engine,
GenDx, Utrecht, the Netherlands) for allele assignment
allows reproducibility of results and reduces human
error. It is possible that sequencing exon 2 of DLA
alleles may have identified associated, but not causative,
polymorphisms [57], due to the high degree of linkage
disequilibrium in the canine genome. Therefore, follow-
up functional studies will be required to determine
whether the DLA haplotype associations identified here
represent linked or causative polymorphisms. Future
work would also benefit from additional samples to
allow analysis in a broader range of breeds and a consist-
ent number of cases/controls of each breed. It would
also be interesting to carry out pedigree studies in dia-
betic dogs, considering the MHC haplotypes and disease
history of relatives of DM cases. In the future, it may be
possible to evaluate an expanded MHC profile (including
other genes within this region) from whole genome se-
quencing and increase the size of the study cohorts
through the use of publicly accessible genotyping data
for different dog breeds.
The identification of ‘protective’ DLA haplotypes
should also be interpreted with caution. In some cases,
an allele is present at low frequency in a population, only
because a risk allele is present at a relatively high fre-
quency, rather than because it confers protection from
disease. This may be the case in Cocker Spaniels in the
present study, where there is one dominant ‘risk’ haplo-
type and the ‘protective’ haplotypes occur at much lower
frequency. Larger sample numbers, or exclusion of cases
with the dominant risk haplotype in future studies, may
help to clarify the importance of the protective associa-
tions. Protective MHC haplotypes are documented in
human T1D, for example the DRB1*15:01--DQA1*01:
02--DQB1*06:02 (HLA-DR2) haplotype which exerts a
dominant protective effect in Caucasians [58]. Carriage
of this haplotype is highly protective [59], although the
effect is not consistent across all ethnic populations and
there is some evidence to suggest that the protective ef-
fect is modified by other HLA loci [60].
Given the important role of the MHC in the adaptive im-
mune system, the associations identified here support an
immune-mediated component to the pathogenesis of
disease in some cases of canine DM in some breeds. The
associations identified in the Cocker Spaniel, a breed pre-
disposed to autoimmune disease, warrant further follow-up
to determine what proportion of diabetic Cocker Spaniels
may have an immune-mediated component to the disease.
In the DM high-risk breeds, with no DLA associations
identified in this study, there remains a high degree of un-
certainty surrounding the aetiology of their hyperglycaemia.
This once again emphasises the heterogenous nature of ca-
nine DM, with different mechanisms leading to beta cell
loss and insulin deficiency from breed to breed, and
immune-mediated disease playing a role in only a propor-
tion of dogs. In the absence of strong histological or sero-
logical evidence of an immune-mediated process being
responsible for many cases of canine DM, our data suggest
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that focus of future investigations in this area should be on
breeds where DLA genes do appear to influence disease
risk. This could apply to future studies of autoantibodies in
canine DM, which previously have not consistently identi-
fied circulating autoantibodies [9–12]. In addition, pancre-
atic necropsy studies in dogs euthanased at or around the
time of diagnosis of DM may provide further insight into
the histopathological changes in the pancreas during early
stages of disease, and could be supported by breed clubs in
those breeds where DM is particularly prevalent.
The present findings also emphasise the need for a
better understanding of the mechanistic role of canine
MHC class II proteins in immunity/immunopathology,
particularly in relation how allelic variants associated
with disease risk or protection modify the structure and
function of MHC molecules, including the peptides they
can present. The class II MHC genes confer > 50%
genetic risk in human T1D [61] and may also be highly
important in immune-mediated forms of canine DM.
However, the heterogeneity identified between breeds in
this study highlights the need to consider the other gen-
etic and environmental factors which interact to deter-
mine an individual’s overall disease risk.
Although these findings are not yet relatable to clinical
diagnosis or management of canine DM, they highlight the
importance of work to better classify the phenotypes/sub-
types of canine DM, similar to the subdivision of human
DM patients into T1D, T2D and other forms of disease.
This will help to strengthen the power of future analyses by
reducing the risk of including disease phenocopies (individ-
uals with the same clinical signs but different pathogenesis
to their disease) in study cohorts. Furthermore, a better un-
derstanding of how MHC haplotypes influence risk of ca-
nine DM may allow stratification of cohorts for clinical
research projects according to genotype, which will im-
prove statistical power. In the era of precision medicine, it
is possible that canine DM cases where immune-mediated
pancreatic destruction can be proven to be responsible for
clinical signs may benefit from different management strat-
egies compared to cases with insulin antagonism/resistance
or exocrine pancreatic disease.
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